Publications en collaboration avec des chercheurs de Instituto de Investigaciones Biomédicas Alberto Sols (9)

2019

  1. Protective Role of Hepatocyte Cyclooxygenase-2 Expression Against Liver Ischemia–Reperfusion Injury in Mice

    Hepatology, Vol. 70, Núm. 2, pp. 650-665

2018

  1. Disruption of tumor necrosis factor alpha receptor 1 signaling accelerates NAFLD progression in mice upon a high-fat diet

    Journal of Nutritional Biochemistry, Vol. 58, pp. 17-27

  2. PGE2 induces apoptosis of hepatic stellate cells and attenuates liver fibrosis in mice by downregulating miR-23a-5p and miR-28a-5p

    Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1864, Núm. 2, pp. 325-337

2017

  1. Benznidazole, the trypanocidal drug used for Chagas disease, induces hepatic NRF2 activation and attenuates the inflammatory response in a murine model of sepsis

    Toxicology and Applied Pharmacology, Vol. 315, pp. 12-22

2016

  1. Cyclooxygenase-2 expression in hepatocytes attenuates non-alcoholic steatohepatitis and liver fibrosis in mice

    Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1862, Núm. 9, pp. 1710-1723

2015

  1. Hepatic cyclooxygenase-2 expression protects against diet-induced steatosis, obesity, and insulin resistance

    Diabetes, Vol. 64, Núm. 5, pp. 1522-1531

  2. Regulation of microRNA 183 by cyclooxygenase 2 in liver is DEAD-box helicase p68 (DDX5) dependent: Role in insulin signaling

    Molecular and Cellular Biology, Vol. 35, Núm. 14, pp. 2554-2567

2013

  1. Regulation of 15-hydroxyprostaglandin dehydrogenase expression in hepatocellular carcinoma

    International Journal of Biochemistry and Cell Biology, Vol. 45, Núm. 11, pp. 2501-2511

2012

  1. Cyclooxygenase-2 Is a Target of MicroRNA-16 in Human Hepatoma Cells

    PLoS ONE, Vol. 7, Núm. 11